Search results for: 'point pharmaceutical'

The U.S. Point-of-Care Retail Diagnostic report focuses on the largest segments of this market, pregnancy and ovulation. This report includes revenues and market share information, as well as a forecast to 2009, using 2002 as the base year. The study includes detailed analysis of market trends, challenges, drivers, strategies, pricing and demand....

This research service provides an outlook of the U.S. generic pharmaceuticals market and includes the unbranded generic drugs sold within the U.S. The research service provides a market overview, trends, competitive landscape, market forecasts, market share analysis, industry challenges and opportunities.

This research service examines the water and wastewater management related opportunities in the global pharmaceutical industry covering the buying pattern, market entry routes, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for regional and market segments are forecasted. In addition, an i...

11 Nov 2015  |  Asia Pacific  |  Market Research

Asia-Pacific Point-of-Care Testing Market

Trends, Challenges, and Best Practices for Stakeholders

Infographics

×

Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

This research service covers the North American IP telephony end-point markets including deskphones and softphones. The research service discusses market challenges, drivers, restraints and trends. It provides a competitive analysis and a unit shipment and revenue forecast.

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Govern...